Cardinal Capital Management Inc (North Carolina)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,950
Closed -$204K 123
2017
Q4
$204K Hold
1,950
0.06% 118
2017
Q3
$284K Hold
1,950
0.09% 119
2017
Q2
$253K Hold
1,950
0.08% 117
2017
Q1
$243K Hold
1,950
0.09% 117
2016
Q4
$226K Hold
1,950
0.09% 117
2016
Q3
$204K Buy
+1,950
New +$211K 0.08% 115
2016
Q1
Sell
-1,950
Closed -$234K 122
2015
Q4
$234K Hold
1,950
0.1% 116
2015
Q3
$211K Hold
1,950
0.1% 113
2015
Q2
$226K Hold
1,950
0.1% 118
2015
Q1
$225K Hold
1,950
0.1% 116
2014
Q4
$218K Buy
+1,950
New +$206K 0.1% 107

Other funds holding CELG

Cardinal Capital Management Inc (North Carolina)'s CELG Position: Q1 2018 in Review

Cardinal Capital Management Inc (North Carolina) sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 1,950 shares — an estimated $204K sold.

Cardinal Capital Management Inc (North Carolina) first reported a position in CELG in Q4 2014 and held it in 11 quarters. The position peaked at $284K in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Cardinal Capital Management Inc (North Carolina) reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Cardinal Capital Management Inc (North Carolina) sold 1,950 Celgene Corp shares in Q1 2018, an estimated $204K.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Celgene Corp in Q4 2014 and held it in 11 quarters.
  • Cardinal Capital Management Inc (North Carolina)'s Celgene Corp position peaked at $284K in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q1 2018, filed 25 Apr 2018.